Pomdoctor vs TheRealReal
POM and REAL side by side, both in miscellaneous retail. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How POM and REAL compare
TheRealReal grew revenue faster over the last twelve months (18.1% versus 16.7% for Pomdoctor).
TheRealReal scores higher on the StockData Score (5 against 1 for Pomdoctor), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | POM | REAL |
|---|---|---|
| Size and price | ||
| Market cap | – | $1.8B |
| Share price | $1.62 | $14.53 |
| Change, 1 year | −98.3% | −1.6% |
| Change, 5 years | – | −5.8% |
| Beta (5Y) | 1.22 | 2.89 |
| Employees | 10K | 3,140 |
| StockData Score | ||
| Total score | 1 | 5 (better) |
| Valuation score | 0 | 0 |
| Growth score | 1 | 3 (better) |
| Performance score | 0 | 1 (better) |
| Health score | 0 | 1 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 2.3× |
| EV/EBITDA | – | 51.9× |
| P/FCF | – | 52.3× |
| FCF yield | – | 1.9% |
| Growth | ||
| Revenue growth (TTM) | 16.7% | 18.1% (better) |
| Revenue growth, 5Y average | – | 18.2% |
| Profitability | ||
| Gross margin | 13.1% | 74.7% (better) |
| Operating margin | −29.7% | 0.41% (better) |
| Net margin | – | −1.4% |
| FCF margin | −37.4% | 4.4% (better) |
| Financial health | ||
| Net debt / EBITDA | – | 0.49 |
| Interest coverage | −30.1× | 0.1× (better) |
| Current ratio | 0.35 | 0.84 (better) |
| Altman Z-score | – | −1.13 |
| Piotroski F-score | – | 5 |
| Dividends and buybacks | ||
| Shareholder yield | – | 0.00% |
| Ownership | ||
| Held by institutions | 0.11% | 90.7% |
| Held by insiders | 28.1% | 7.9% |
| Insider net buying, 12 months | – | −$10.7M |
| Short interest, % of float | – | 15.4% |
Go deeper
- POM stock overview
- POM income statement
- POM valuation and score
- REAL stock overview
- REAL income statement
- REAL valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.